Second generation cephalosporin antibiotic Mefoxin (brand name Cefoxitin) binds to bacterial cell walls causing cell death and is used to treat many bacterial infections including severe or life threatening forms. It is given as 1g intravenous every 8 hours to patients with hypersensitivity to cephalosporins or penicillin. Nurses must properly identify the patient, observe rights, monitor for side effects like rashes, seizures or phlebitis, and encourage reporting of any unusual effects.
Second generation cephalosporin antibiotic Mefoxin (brand name Cefoxitin) binds to bacterial cell walls causing cell death and is used to treat many bacterial infections including severe or life threatening forms. It is given as 1g intravenous every 8 hours to patients with hypersensitivity to cephalosporins or penicillin. Nurses must properly identify the patient, observe rights, monitor for side effects like rashes, seizures or phlebitis, and encourage reporting of any unusual effects.
Second generation cephalosporin antibiotic Mefoxin (brand name Cefoxitin) binds to bacterial cell walls causing cell death and is used to treat many bacterial infections including severe or life threatening forms. It is given as 1g intravenous every 8 hours to patients with hypersensitivity to cephalosporins or penicillin. Nurses must properly identify the patient, observe rights, monitor for side effects like rashes, seizures or phlebitis, and encourage reporting of any unusual effects.
Generic Name: Second generation Binds to bacterial cell Is used to treat Patients with -Redness -Check and verify
-Check and verify with
Mefoxin cephalosporins wall membrane, or prevent hypersensitivity -Nausea doctor’s order. causing cell death. many kinds of to cephalosporin, -Vomiting -Identify the right patient by Brand Name: bacterial penicillin. -Diarrhea asking her/his name. Cefoxitin infections, -Cramps -Observe rights in including -Rashes medication administration. Dose, route, severe or life- -Seizures -Assess and monitor for frequency: 1g IV q 8 threatening -Phlebitis at IV site signs of hypersensitivity to forms. drug. -Assess and monitor vital signs before and after administration. -Monitor site frequently -Encouraged patient to report any unusual effects of medications.